New enzyme replacement therapy to treat rare genetic disorder alpha-mannosidosis in children and adults

View source ↗

Summary

EMA announces approval of a new enzyme replacement therapy for alpha-mannosidosis, a rare genetic disorder, for use in children and adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-mannosidosis